Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of TWINRIX ADULT 2-dose schedule in children 1–11 years
2015-001516-35Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV), sponsored by GSK. Primary endpoint: Immunogenicity (primary).
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2015-001516-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001516-35.